Assessment of HIV-1 subtyping for Cameroon strains using phylogenetic analysis of pol gene sequences

Journal of Virological Methods

Volumn 110, Issue 1, 2003, Pages 1-8

  Njouom, Richard ^a   Pasquier, Christophe ^a   Sandres Sauné, Karine ^a   Harter, Agnès ^a   Souyris, Corinne ^a   Izopet, Jacques ^a  

^a CHU PURPAN   (France)

Author keywords

Cameroon; Env; HIV 1; Plasma; Pol; Subtypes

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS STRAIN; VIRUS TYPING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037904614     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(03)00080-6     Document Type: Article

References (30)

1. Carr J., Torimiro J., Wolfe N., Eitel M., Kim B., Sanders-Buell E., Jagodzinski L., Gotte D., Burke D., Birx D., McCutchan F. The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology. 286:(1):2001;168-181.
2. Descamps D., Calvez V., Izopet J., Buffet-Janvresse C., Schmuck A., Colson P., Ruffault A., Maillard A., Masquelier B., Cottalorda J., Harzic M., Brun-Vezinet F., Costagliola D. Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study. AIDS. 15:(14):2001;1777-1782.
3. Fonjungo P., Mpoudi E., Torimiro J., Alemnji G., Eno L., Nkengasong J., Gao F., Rayfield M., Folks T., Pieniazek D., Lal R. Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon. AIDS Res. Hum. Retroviruses. 16:(13):2000;1319-1324.
4. Fonjungo P., Mpoudi E., Torimiro J., Alemnji G., Eno L., Lyonga E., Nkengasong J., Lal R., Rayfield M., Kalish M., Folks T., Pieniazek D. Human immunodeficiency virus type 1 group M protease in Cameroon: genetic diversity and protease inhibitor mutational features. J. Clin. Microbiol. 40:(3):2002;837-1370.
5. Gao F., Robertson D.L., Carruthers C.D., Morrison S.G., Jian B., Chen Y., Barre-Sinoussi F., Girard M., Srinivasan A., Abimiku A.I.G., Shaw G.M., Sharp P.M., Hahn B.H. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J. Virol. 72:(7):1998;5680-5698.
6. Gurtler L., Hauser P., Eberle J., von Brunn A., Knapp S., Zekeng L., Tsague J., Kaptue L. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J. Virol. 68:(3):1994;1581-1585.
7. Heyndrickx L., Janssens W., Ndumbe P., Vereecken K., Coppens S., De Houwer K., Fransen K., Van der Auwera G., van der Groen G. HIV-1 genetic variability in Cameroon. AIDS. 14:(12):2000;1862-1864.
8. Hirsch M.S., Brun-Vezinet F., D'Aquila R.T., Hammer S.M., Johnson V.A., Kuritzkes D.R., Loveday C., Mellors J.W., Clotet B., Conway B., Demeter L.M., Vella S., Jacobsen D.M., Richman D.D. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society - USA Panel. JAMA. 283:(18):2000;2417-2426.
9. Izopet J., Massip P., Souyris C., Sandres K., Puissant B., Obadia M., Pasquier C., Bonnet E., Marchou B., Puel J. Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen. AIDS. 14:(15):2000;2247-2255.
10. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:(2):1980;111-120.
11. Koch N., Ndihokubwayo J., Yahi N., Tourres C., Fantini J., Tamalet C. Genetic analysis of HIV type 1 strains in Bujumbura (Burundi): predominance of subtype C variant. AIDS Res. Hum. Retroviruses. 17:(3):2001;269-273.
12. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., Ingersoll R., Sheppard H.W., Ray S.C. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73:1999;152-160.
13. Mboudjeka I., Zekeng L., Takehisa J., Miura T., Ido E., Yamashita M., Kaptue L., Hayami M. HIV type 1 genetic variability in the northern part of Cameroon. AIDS Res. Hum. Retroviruses. 15:(11):1999;951-956.
14. Montavon C., Toure-Kane C., Liegeois F., Mpoudi E., Bourgeois A., Vergne L., Perret J., Boumah A., Saman E., Mboup S., Delaporte E., Peeters M. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J. Acquired Immune Defic. Syndrome. 23:(5):2000;363-374.
15. Montavon C., Vergne L., Bourgeois A., Mpoudi-Ngole E., Malonga-Mouellet G., Butel C., Toure-Kane C., Delaporte E., Peeters M. Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. AIDS Res. Hum. Retroviruses. 18:(3):2002;231-236.
16. Nijhuis M., Boucher C.A.B., Schipper P., Leitner T., Schuurman R., Albert J. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. PNAS. 95:(24):1998;14441-14446.
17. Nkengasong J., Janssens W., Heyndrickx L., Fransen K., Ndumbe P., Motte J., Leonaers A., Ngolle M., Ayuk J., Piot P. Genotypic subtypes of HIV-1 in Cameroon. AIDS. 8:(10):1994;1405-1412.
18. Nyambi P., Heyndrickx L., Vereecken K., Burda S., De Houwer K., Coppens S., Urbanski M., Williams C., Ndumbe P., Janssens W. Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns. AIDS. 16:(2):2002;295-296.
19. Pasquier C., Millot N., Njouom R., Sandres K., Cazabat M., Puel J., Izopet J. HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J. Virol. Methods. 94:(1-2):2001;45-54.
20. Robertson D.L., Anderson J.P., Bradac J.A., Carr J.K., Foley B., Funkhouser R.K., Gao F., Hahn B.H., Kalish M.L., Kuiken C., Learn G.H., Leitner T., McCutchan F., Osmanov S., Peeters M., Pieniazek D., Salminen M., Sharp P.M., Wolinsky S., Korber B. HIV-1 nomenclature proposal. Science. 288:(5463):2000;55-56.
21. Salminen M., Koch C., Sanders-Buell E., Ehrenberg P., Michael N., Carr J., Burke D., McCutchan F. Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology. 213:(1):1995;80-86.
22. Simon F., Mauclere P., Roques P., Loussert-Ajaka I., Muller-Trutwin M., Saragosti S., Georges-Courbot M., Barre-Sinoussi F., Brun-Vezinet F. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 4:(9):1998;1032-1037.
23. Takehisa J., Zekeng L., Ido E., Mboudjeka I., Moriyama H., Miura T., Yamashita M., Gurtler L., Hayami M., Kaptue L. Various types of HIV mixed infections in Cameroon. Virology. 245:(1):1998;1-10.
24. Takehisa J., Zekeng L., Ido E., Yamaguchi-Kabata Y., Mboudjeka I., Harada Y., Miura T., Kaptue L., Hayami M. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J. Virol. 73:(8):1999;6810-6820.
25. Tamalet C., Pasquier C., Yahi N., Colson P., Poizot-Martin I., Lepeu G., Gallais H., Massip P., Puel J., Izopet J. Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection. J. Med. Virol. 61:(2):2000;181-186.
26. Tebit D., Zekeng L., Kaptue L., Salminen M., Krausslich H., Herchenroder O. Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. AIDS Res. Hum. Retroviruses. 18:(1):2002;39-48.
27. Thompson J., Higgins D., Gibson T. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:(22):1994;4673-4680.
28. Tscherning-Casper C., Dolcini G., Mauclere P., Fenyo E., Barre-Sinoussi F., Albert J., Menu E. Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon. The European Network on the Study of In Utero Transmission of HIV-1. AIDS Res. Hum. Retroviruses. 16:(13):2000;1313-1318.
29. Wilbe K., Casper C., Albert J., Leitner T. Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon. AIDS Res. Hum. Retroviruses. 18:(12):2002;849-856.
30. Yahi N., Fantini J., Tourres C., Tivoli N., Koch N., Tamalet C. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. J. Infect. Dis. 183:2001;1311-1317.